Explore journal overview, editorial leadership, indexing, articles in press, latest published work, and highlights from previous issues.
Antibody therapy: Antibodies are a key component of the adaptive immune response, playing a central role in both recognizing foreign antigens and stimulating immune response. Antibodies are Y-shaped proteins produced by some B cells and are composed of two regions: an antigen-binding fragment (Fab), which binds to antigens, and a Fragment crystallizable (Fc) region, which interacts with so-called Fc receptors that are expressed on the surface of different immune cell types including macrophages, neutrophils and NK cells. Many immunotherapeutic regimens involve antibodies. Monoclonal antibody technology engineers and generates antibodies against specific antigens, such as those present on tumor surfaces. These antibodies that are specific to the antigens of the tumor, can then be injected into a tumor
Two types are used in cancer treatments naked monoclonal antibodies and Conjugated monoclonal antibodies are joined to another molecule
Edelweiss: Cancer Open Access is an open access journal which aims to publish most complete and genuine source of information in the form of short commentary, mini review, case report, related, but not limited to above areas and making them available freely through online without any subscriptions and restrictions to researches worldwide
Researchers, authors, reviewers, and readers can use this page to find journal resources connected with Antibody therapy, including published articles, related academic topics, current issue content, archive material, and manuscript submission information.
Related article links for Antibody therapy will appear here as matching content is published in Edelweiss: Cancer Open Access (ISSN: 2689-6737). Readers can also browse the journal archive and current issue for connected research.
